Workplace bullying and workplace violence as risk factors for cardiovascular disease: a multi-cohort study.


Journal

European heart journal
ISSN: 1522-9645
Titre abrégé: Eur Heart J
Pays: England
ID NLM: 8006263

Informations de publication

Date de publication:
07 04 2019
Historique:
received: 07 04 2018
revised: 15 07 2018
accepted: 08 10 2018
pubmed: 20 11 2018
medline: 26 5 2020
entrez: 20 11 2018
Statut: ppublish

Résumé

To assess the associations between bullying and violence at work and cardiovascular disease (CVD). Participants were 79 201 working men and women, aged 18-65 years and free of CVD and were sourced from three cohort studies from Sweden and Denmark. Exposure to workplace bullying and violence was measured at baseline using self-reports. Participants were linked to nationwide health and death registers to ascertain incident CVD, including coronary heart disease and cerebrovascular disease. Study-specific results were estimated by marginal structural Cox regression and were combined using fixed-effect meta-analysis. Nine percent reported being bullied at work and 13% recorded exposure to workplace violence during the past year. We recorded 3229 incident CVD cases with a mean follow-up of 12.4 years (765 in the first 4 years). After adjustment for age, sex, country of birth, marital status, and educational level, being bullied at work vs. not was associated with a hazard ratio (HR) of 1.59 [95% confidence interval (CI) 1.28-1.98] for CVD. Experiencing workplace violence vs. not was associated with a HR of 1.25 (95% CI 1.12-1.40) for CVD. The population attributable risk was 5.0% for workplace bullying and 3.1% for workplace violence. The excess risk remained similar in analyses with different follow-up lengths, cardiovascular risk stratifications, and after additional adjustments. Dose-response relations were observed for both workplace bullying and violence (Ptrend < 0.001). There was only negligible heterogeneity in study-specific estimates. Bullying and violence are common at workplaces and those exposed to these stressors are at higher risk of CVD.

Identifiants

pubmed: 30452614
pii: 5180493
doi: 10.1093/eurheartj/ehy683
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1124-1134

Subventions

Organisme : Medical Research Council
ID : MR/K013351/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R024227/1
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2018. For permissions, please email: journals.permissions@oup.com.

Auteurs

Tianwei Xu (T)

Section of Epidemiology, Department of Public Health, University of Copenhagen, Gothersgade 160, DK-1123 Copenhagen, Denmark.
Division for Epidemiology, Stress Research Institute, Stockholm University, SE-10691, Stockholm, Sweden.
National Research Centre for the Working Environment, Lersø Parkallé 105, DK-2100 Copenhagen, Denmark.

Linda L Magnusson Hanson (LL)

Division for Epidemiology, Stress Research Institute, Stockholm University, SE-10691, Stockholm, Sweden.

Theis Lange (T)

Section of Biostatistics, Department of Public Health, University of Copenhagen, Øster Farimagsgade 2A, DK-1353 Copenhagen, Denmark.
Centre for Statistical Science, Peking University, No. 5 Yiheyuan Road, Beijing CN-100871, China.

Liis Starkopf (L)

Section of Biostatistics, Department of Public Health, University of Copenhagen, Øster Farimagsgade 2A, DK-1353 Copenhagen, Denmark.

Hugo Westerlund (H)

Division for Epidemiology, Stress Research Institute, Stockholm University, SE-10691, Stockholm, Sweden.

Ida E H Madsen (IEH)

National Research Centre for the Working Environment, Lersø Parkallé 105, DK-2100 Copenhagen, Denmark.

Reiner Rugulies (R)

Section of Epidemiology, Department of Public Health, University of Copenhagen, Gothersgade 160, DK-1123 Copenhagen, Denmark.
National Research Centre for the Working Environment, Lersø Parkallé 105, DK-2100 Copenhagen, Denmark.
Department of Psychology, University of Copenhagen, Øster Farimagsgade 2A, DK-1353 Copenhagen, Denmark.

Jaana Pentti (J)

Department of Public Health, University of Turku and Turku University Hospital, FI-20014 Turku, Finland.

Sari Stenholm (S)

Department of Public Health, University of Turku and Turku University Hospital, FI-20014 Turku, Finland.

Jussi Vahtera (J)

Department of Public Health, University of Turku and Turku University Hospital, FI-20014 Turku, Finland.

Åse M Hansen (ÅM)

National Research Centre for the Working Environment, Lersø Parkallé 105, DK-2100 Copenhagen, Denmark.
Section of Social Medicine, Department of Public Health, University of Copenhagen, Gothersgade 160, DK-1123 Copenhagen, Denmark.

Marianna Virtanen (M)

Division for Epidemiology, Stress Research Institute, Stockholm University, SE-10691, Stockholm, Sweden.
Finnish Institute of Occupational Health, Topeliuksenkatu 41 b, FI-00250 Helsinki, Finland.
Department of Public Health and Caring Sciences, University of Uppsala, Husargatan 3, Uppsala, Sweden.

Mika Kivimäki (M)

Finnish Institute of Occupational Health, Topeliuksenkatu 41 b, FI-00250 Helsinki, Finland.
Department of Epidemiology and Public Health, University College London, 1-19 Torrington Place, London, UK.
Clinicum, Faculty of Medicine, PO Box 63, FI-00014 University of Helsinki, Helsinki, Finland.

Naja H Rod (NH)

Section of Epidemiology, Department of Public Health, University of Copenhagen, Gothersgade 160, DK-1123 Copenhagen, Denmark.
Division for Epidemiology, Stress Research Institute, Stockholm University, SE-10691, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH